Detection of mutations in an extensive panel of 55 genes that have been associated with an increased predisposition to a wide range of cancers (such as breast, colorectal, prostate, pancreatic, ovarian, stomach, melanoma, thyroid, kidney and/or endometrial).

The test is performed on blood samples using Next Generation Sequencing (NGS) and Multiplex Ligation-dependent Probe Amplification (MLPA) methodologies.